Fresh from First SRS Renewal, BioWisdom Readies Version 8.2, Mulls Accelerated Integration Roadmap | GenomeWeb

BioWisdom this week announced that Boehringer Ingelheim has extended its license for SRS and SRS Prisma for another year — the first such renewal that BioWisdom has announced since acquiring the SRS business from Lion Bioscience last month [BioInform 04-07-06].

Under the terms of the deal, Boehringer Ingelheim has agreed to upgrade its Biberach, Germany, and Ridgefield, NJ, sites to new versions of the software. The company has been using SRS as part of its bioinformatics infrastructure for five years.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.